alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › antibody

antibody

2 studies tagged antibody, dated 2002-03-01 to 2022-01-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Discovery and engineering of an anti-TREM2 antibody to promote amyloid plaque clearance by microglia in 5XFAD mice 2022-01-01
  2. The intracellular antibody capture technology (IACT): towards a consensus sequence for intracellular antibodies 2002-03-01

Studies

2 studies carry this tag.

Date range

2002 to 2022

Top journals

  • Journal of molecular biology 1
  • mAbs 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Discovery and engineering of an anti-TREM2 antibody to promote amyloid plaque clearance by microglia in 5XFAD mice

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. mAbs 2022-01-01 TREM2 and immune genetics

    Triggering receptor expressed on myeloid cells 2 (TREM2) plays a crucial role in regulating microglial functions and removal of amyloid plaques in Alzheimer's disease (AD).

  2. The intracellular antibody capture technology (IACT): towards a consensus sequence for intracellular antibodies

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of molecular biology 2002-03-01 Genetics

    We describe the application of an intracellular antibody capture technology (IACT) as a generic in vivo selection procedure for isolating intracellular antibodies or ICAbs.

All topic tags with their study counts